KalVista Pharmaceuticals, Inc. (KALV)

14.85 -1.05 (-6.60%) USD  |  NASDAQ  |  Dec 17, 16:00
14.84 -0.01 (-0.07%) After-Hours: 20:00
More

KalVista Pharmaceuticals Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade
BeyondSpring, Inc. Upgrade